|
DE1092476B
(de)
|
1958-04-24 |
1960-11-10 |
Rhone Poulenc Sa |
Verfahren zur Herstellung von Phenthiazinderivaten
|
|
BE786583A
(fr)
|
1971-07-21 |
1973-01-22 |
Rhone Poulenc Sa |
Nouveaux derives de la phenothiazine, leur preparation et les compositions qui les contiennent
|
|
IT1202370B
(it)
|
1976-07-12 |
1989-02-09 |
Hoffmann La Roche |
Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
|
|
DE2914788A1
(de)
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
|
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4412999A
(en)
|
1982-04-14 |
1983-11-01 |
Merck & Co., Inc. |
Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
|
GB8424709D0
(en)
|
1984-10-01 |
1984-11-07 |
Minnesota Mining & Mfg |
Azine redox dyes and leuco azine dyes
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
US4959217A
(en)
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
|
US4925678A
(en)
|
1987-04-01 |
1990-05-15 |
Ranney David F |
Endothelial envelopment drug carriers
|
|
US5080646A
(en)
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US5244925A
(en)
|
1987-12-18 |
1993-09-14 |
Kabi Pharmacia Aktiebolag |
Emulsion for parenteral administration
|
|
GB2228412B
(en)
|
1989-02-28 |
1993-04-14 |
Syntex Inc |
Nicardipine pharmaceutical composition for parenteral administration
|
|
IT1230881B
(it)
|
1989-06-20 |
1991-11-08 |
Angeli Inst Spa |
Derivati del r(-) 3-chinuclidinolo
|
|
US5167616A
(en)
|
1989-12-14 |
1992-12-01 |
Alza Corporation |
Iontophoretic delivery method
|
|
DK203990D0
(da)
|
1990-08-24 |
1990-08-24 |
Novo Nordisk As |
Piperazinylderivater
|
|
US5225182A
(en)
|
1991-10-31 |
1993-07-06 |
Sharma Yash P |
Vectored drug delivery system using a cephaloplastin linking agent and a methed of using the system
|
|
US5434174A
(en)
|
1992-07-17 |
1995-07-18 |
Eli Lilly And Company |
Isoxazole derivatives for the treatment of irritable bowel syndrome
|
|
US5437291A
(en)
|
1993-08-26 |
1995-08-01 |
Univ Johns Hopkins |
Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
EP0835129B1
(en)
|
1995-06-30 |
2003-10-29 |
Novo Nordisk A/S |
Prevention of a disease having the characteristics of diabetes
|
|
GB9606076D0
(en)
|
1996-03-22 |
1996-05-22 |
Univ Birmingham |
Diabetes treatment
|
|
US6756056B2
(en)
*
|
1997-04-08 |
2004-06-29 |
Alan A. Rubin |
Treatment of Parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa
|
|
US7098232B1
(en)
|
1999-10-22 |
2006-08-29 |
Athpharma Limited |
Treatment and prevention of gastrointestinal disease using antagonists of partial agonists of 5HT1a receptors
|
|
US7122198B1
(en)
*
|
1999-11-30 |
2006-10-17 |
Panacea Biotec Limited |
Fast dissolving composition with prolonged sweet taste
|
|
US20030176421A1
(en)
|
1999-12-30 |
2003-09-18 |
Watson John W. |
Prokinetic agents for treating gastric hypomotility and related disorders
|
|
US6239122B1
(en)
|
2000-01-05 |
2001-05-29 |
Joy Ann Steele |
Method of treatment of nausea, vomiting, and other disorders using estrogens
|
|
IL155667A0
(en)
|
2000-11-15 |
2003-11-23 |
Tap Pharmaceutical Prod Inc |
Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
|
|
US20020108869A1
(en)
|
2001-02-09 |
2002-08-15 |
Alex Savtchenko |
Device and technique for multiple channel patch clamp recordings
|
|
US20070129307A1
(en)
|
2001-06-22 |
2007-06-07 |
The University Of British Columbia |
Insulin epitopes for the treatment of type 1 diabetes
|
|
GB2389791B
(en)
|
2002-04-30 |
2006-12-13 |
Steven Gill |
Implantable drug delivery pump
|
|
FR2845914B1
(fr)
|
2002-10-18 |
2005-11-04 |
Schwarz Pharma Lab |
Compose antiemetique a desagregation rapide
|
|
US7618948B2
(en)
|
2002-11-26 |
2009-11-17 |
Medtronic, Inc. |
Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
|
|
KR20050111318A
(ko)
|
2003-01-13 |
2005-11-24 |
다이노젠 파마세우티컬스, 인코포레이티드 |
기능성 장 질환을 치료하는 방법
|
|
US20040172084A1
(en)
|
2003-02-03 |
2004-09-02 |
Knudson Mark B. |
Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
|
|
CA2519357A1
(en)
|
2003-03-17 |
2004-09-30 |
Pfizer Products Inc. |
Treatment of type 1 diabetes with pde5 inhibitors
|
|
JP2006522817A
(ja)
|
2003-04-08 |
2006-10-05 |
プロジェニックス ファーマシューティカルズ，インコーポレーテッド |
過敏性腸症候群を処置するための末梢オピオイドアンタゴニスト、特にメチルナルトレキソンの使用
|
|
US8815950B2
(en)
*
|
2003-08-29 |
2014-08-26 |
Janssen Biotech, Inc. |
Pharmaceutical compositions and method of using levodopa and carbidopa
|
|
US7358271B2
(en)
|
2003-09-05 |
2008-04-15 |
Williamsburg Holdings Llc |
Sulpiride pharmaceutical compositions
|
|
US20060287221A1
(en)
|
2003-11-13 |
2006-12-21 |
Novo Nordisk A/S |
Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
|
|
AU2005272598B2
(en)
|
2004-08-12 |
2011-11-17 |
Helsinn Therapeutics (U.S.), Inc. |
Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
|
|
US7659306B2
(en)
|
2004-11-03 |
2010-02-09 |
The Board Of Regents Of The University Of Texas System |
Method of increasing gastric emptying
|
|
MX2007007626A
(es)
*
|
2004-12-22 |
2008-01-28 |
Johnson & Johnson |
Moduladores delta-opioides triciclicos.
|
|
US20090054319A1
(en)
|
2005-03-17 |
2009-02-26 |
Microbia, Inc. |
Methods and Compositions for the Treatment of Hypertension and Gastrointestinal Disorders
|
|
US20070016262A1
(en)
|
2005-07-13 |
2007-01-18 |
Betastim, Ltd. |
Gi and pancreatic device for treating obesity and diabetes
|
|
EP1940441A4
(en)
|
2005-08-19 |
2010-01-27 |
Ironwood Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
|
|
WO2008002971A2
(en)
|
2006-06-29 |
2008-01-03 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
CN101677997B
(zh)
|
2007-03-30 |
2012-05-09 |
泰奥加制药公司 |
用于治疗腹泻型和交替型肠易激综合征的κ-阿片剂激动剂
|
|
CA2685362A1
(en)
*
|
2007-04-26 |
2008-11-06 |
Craig A. Aronchick |
Compositions and methods for transmucosal delivery of domperidone
|
|
WO2008141074A1
(en)
|
2007-05-10 |
2008-11-20 |
Salk Institute For Biological Studies |
Identification of compounds that protect against amyloid diseases
|
|
US7930033B2
(en)
|
2007-08-17 |
2011-04-19 |
Jianfeng Chen |
Appendicular and rectal stimulator device for digestive and eating disorders
|
|
US20090326004A1
(en)
|
2008-06-03 |
2009-12-31 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
|
CN102548555A
(zh)
*
|
2009-07-31 |
2012-07-04 |
克莱拉有限公司 |
用于治疗帕金森病的组合物和方法
|
|
US8349818B2
(en)
|
2009-10-21 |
2013-01-08 |
Wisconsin Alumni Research Foundation |
Method of preventing Type 1 diabetes
|
|
US8417465B2
(en)
|
2009-11-04 |
2013-04-09 |
Cfd Research Corporation |
Synthetic microfluidic blood-brain barrier
|
|
JP5774610B2
(ja)
*
|
2010-03-04 |
2015-09-09 |
オリオン コーポレーション |
パーキンソン病の治療方法
|
|
US8329009B2
(en)
|
2010-04-09 |
2012-12-11 |
Molecular Devices, Llc |
High throughput screening of ion channels
|
|
AU2011268073B2
(en)
|
2010-06-18 |
2015-07-16 |
Takeda Pharmaceutical Company Limited |
D2 antagonists, methods of synthesis and methods of use
|
|
US20120053121A1
(en)
|
2010-08-31 |
2012-03-01 |
Nationwide Children's Hospital, Inc. |
Administration of HB-EGF for the Protection of Enteric Neurons
|
|
US20120101089A1
(en)
|
2010-10-26 |
2012-04-26 |
Ashwani Agarwal |
Anti-Emetic Substance
|
|
WO2013028909A1
(en)
|
2011-08-25 |
2013-02-28 |
Sova Pharmaceuticals, Inc. |
Combination therapy for the treatment of sleep-related breathing disorders
|
|
FR2980976B1
(fr)
|
2011-10-10 |
2015-10-16 |
Mohamed Skiba |
Composition pharmaceutique pour l'administration par voie nasale de la metopimazine
|
|
BR112015015258A2
(pt)
|
2012-12-24 |
2017-09-26 |
Neurogastrx Inc |
métodos para tratar distúrbios do trato gastrintestinal
|
|
IN2013MU02528A
(cg-RX-API-DMAC10.html)
|
2013-07-31 |
2015-06-26 |
Centaur Pharmaceuticals Private Ltd |
|
|
WO2015200369A1
(en)
|
2014-06-24 |
2015-12-30 |
Neurogastrx, Inc. |
Prodrugs of metopimazine
|